These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1838766)

  • 41. Coronary vascular changes in the progression and regression of hypertensive heart disease.
    Strauer BE; Schwartzkopff B; Motz W; Vogt M
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S20-7. PubMed ID: 1720480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The importance of left ventricular hypertrophy in human hypertension.
    Kahan T
    J Hypertens Suppl; 1998 Sep; 16(7):S23-9. PubMed ID: 9855028
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The cardiac structure-function relationship and the renin-angiotensin-aldosterone system in hypertension and heart failure.
    Brilla CG
    Curr Opin Cardiol; 1994 Jul; 9 Suppl 1():S2-10; discussion S10-1. PubMed ID: 7827369
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Angiotensin blockade or calcium antagonists improve endothelial dysfunction in hypertension: studies in perfused mesenteric resistance arteries.
    Dohi Y; Criscione L; Pfeiffer K; Lüscher TF
    J Cardiovasc Pharmacol; 1994 Sep; 24(3):372-9. PubMed ID: 7528292
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new approach to the identification of pathogenetic factors and to therapy in human primary hypertension.
    Korner PI; Jennings GL; Esler MD; Broughton A
    J Clin Hypertens; 1987 Jun; 3(2):187-96. PubMed ID: 2956375
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relation of renin-angiotensin system activity to left ventricular hypertrophy and function in experimental and human hypertension.
    Devereux RB; Pickering TG; Cody RJ; Laragh JH
    J Clin Hypertens; 1987 Mar; 3(1):87-103. PubMed ID: 3033158
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of duration and severity of arterial hypertension and cardiac hypertrophy on coronary vasodilator reserve.
    Wangler RD; Peters KG; Marcus ML; Tomanek RJ
    Circ Res; 1982 Jul; 51(1):10-8. PubMed ID: 6211294
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence for a role for the cardiovascular amplifiers in human primary hypertension.
    Jennings G; Korner PI; Sudhir K; Esler M; Angus JA; Laufer E
    Clin Exp Pharmacol Physiol; 1991 Jan; 18(1):37-41. PubMed ID: 2032389
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vascular and cardiac protection by ramipril in spontaneously hypertensive rats: prevention versus regression study.
    Gohlke P; Linz W; Schölkens B; Van Even P; Martorana P; Unger T
    Br J Clin Pract Suppl; 1996 Jul; 84():1-10. PubMed ID: 8994995
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparable effects of angiotensin II and converting enzyme blockade on hemodynamics and cardiac hypertrophy in spontaneously hypertensive rats.
    Mori T; Nishimura H; Ueyama M; Kubota J; Kawamura K
    Jpn Circ J; 1995 Sep; 59(9):624-30. PubMed ID: 7500546
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Significance of coronary circulation in hypertensive heart disease for development and prevention of heart failure.
    Strauer BE
    Am J Cardiol; 1990 Apr; 65(14):34G-41G. PubMed ID: 2138855
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of different antihypertensive drugs on left ventricular function.
    Oliveri R
    Drugs; 1988; 35 Suppl 6():83-9. PubMed ID: 2969798
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
    Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
    Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chronic arterial vasodilation, central hemodynamics, and cardiac hypertrophy in spontaneously hypertensive rats.
    Yuan B; Leenen FH
    J Cardiovasc Pharmacol; 1992 Jun; 19(6):922-8. PubMed ID: 1376814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resistance vessel structure: effects of treatment.
    Mulvany MJ
    J Cardiovasc Pharmacol; 1991; 17 Suppl 2():S58-63. PubMed ID: 1715487
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiac hypertrophy in diabetic spontaneously hypertensive rats: role of angiotensin II?
    Black MJ; Briscoe T; Bertram JF; Jackson B; Johnston CI
    Clin Exp Pharmacol Physiol; 1997 Jun; 24(6):445-8. PubMed ID: 9171955
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of cardiac hypertrophy in reducing the sensitivity of cardiopulmonary reflex control of renal sympathetic nerve activity in spontaneously hypertensive rats.
    de Andrade TU; Abreu GR; Moysés MR; de Melo Cabral A; Bissoli NS
    Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1104-8. PubMed ID: 18788121
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Kinetics of cardiac and vascular remodeling by spontaneously hypertensive rats after discontinuation of long-term captopril treatment.
    Rocha WA; Lunz W; Baldo MP; Pimentel EB; Dantas EM; Rodrigues SL; Mill JG
    Braz J Med Biol Res; 2010 Apr; 43(4):390-6. PubMed ID: 20379690
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of calcium entry blockade on hypertension-induced left ventricular hypertrophy.
    Frishman WH; Skolnick AE; Strom JA
    Circulation; 1989 Dec; 80(6 Suppl):IV151-61. PubMed ID: 2532080
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of age and dietary sodium on the cardiovascular and renal effects of ramipril in spontaneously hypertensive rats.
    Teräväinen TL; Mervaala EM; Pörsti I; Laakso J; Vapaatalo H; Karppanen H
    Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):311-21. PubMed ID: 9379779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.